Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53

Slides:

Advertisements

Similar presentations

Ethnic differences in risks and explanations for the cardiometabolic syndrome in the UK Nish Chaturvedi Professor of Clinical Epidemiology Imperial College.

Advertisements

Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.

Dr. Chris Cobourn Medical Director and Surgeon Surgical Weight Loss Centre Staff Surgeon Trillium Health Centre Mississauga, Ontario.

Metabolic Syndrome in Non-Diabetics Vilanova Fillat, M.B. Falguera Vilamajó, M. Garriga Badia, A. Miró Vallvé, N. Cebrian Aiguadé, C. Escardó Font, C Bacompte.

U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,

Factors associated with prediabetes in adult children of patients with premature coronary heart disease; the study of families of patients with premature.

ADVICE. Advice Strongly advise adherence to diet and medication Smoking cessation, exercise, weight reduction Ensure diabetes education and advise Diabetes.

Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.

Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?

Cardiovascular Disease in Women Module III: Risk Assessment Tool.

+ Were Hunters and Gatherers Really Healthier Than Us? An Evidence Based Look at the Paleolithic Diet By: Kelsey Starck.

Effects of Low-Fat Dairy Consumption on Markers of Low- Grade Systemic Inflammation and Endothelial Function in Overweight and Obese Subjects: An Intervention.

Obesity M.A.Kubtan MD - FRCS M.A.Kubtan1. 2  Pulmonary Disease  Fatty Liver Disease  Orthopedic Disorders  Gallbladder Disease  Psychological Impact.

METABOLIC Syndrome: a Global Perspective

Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.

SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.

1 The Study of Trandolapril- verapamil And insulin Resistance STAR determined whether glycaemic control was maintained to a greater degree by an RAS inhibitor/non-DHP.

Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]

Conclusion In conclusion, preliminary data from this nutrition intervention study suggest that a well balanced Mediterranean-type diet is able to reduce.

Organizational criteria for Metabolic Syndrome National Cholesterol Education Program Adult Treatment Panel III World Health OrganizationAmerican Association.

Risk of Type 2 Diabetes and It’s Complications Along The Continuum of Fasting Plasma Glucose Gregory A. Nichols, PhD Collaborative Diabetes Education Conference.

GDM-DEFINITION Gestational Diabetes Mellitus (GDM) is defined as ‘carbohydrate intolerance with recognition or onset during pregnancy’, irrespective of.

Ohara C （ Mph ）, Murata A （ MD ）, Inoue M （ MD,PhD ）, Inoue K （ MD,PhD ） Persons with undiagnosed diabetes have worse profiles of cardiovascular and metabolic.

Diabetes National Diabetes Control Programme

METABOLIC SYNDROME From PubMed Health A service of the National Library of Medicine, National Institutes of Health. A.D.A.M. Medical Encyclopedia, Atlanta,

High level of low density lipoprotein cholesterol in adult children of patients with premature coronary heart disease: relation to own and parental characteristics.

HDL LowLess than 40 mg/dL High60 mg/dL and above LDL OptimalLess than 100 mg/dL Near Optimal mg/dL Borderline High mg/dL High mg/dL.

Dr. I. Selvaraj Indian Railways Medical Service B.Sc., M.B.B.S., M.D.,D.P.H., D.I.H., PGCHFW ( NIHFW,New Delhi)., Life member of Indian Association of.

Lesotho STEPS Survey 2012 Fact Sheet John Nkonyana Director Disease Control.

Insulin Resistance Progression to Diabetes. Hypertension: BP >140/90 Dyslipidemia: ◦TG >150 mg/dL (1.7 mmol.L) ◦HDL-C

Chapter 14 Patterns in Health and Disease: Epidemiology and Physiology EXERCISE PHYSIOLOGY Theory and Application to Fitness and Performance, 6th edition.

The short term effects of metabolic syndrome and its components on all-cause-cause mortality-the Taipei Elderly Health Examination Cohort Wen-Liang Liu.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Plasma triglycerides and type III hyperlipidemia.

INTERVENTION IS PREVENTION: For A Healthier Community Bronx County Medical Society 10 th Annual National Doctors Recognition Day March 20, 2013 Julie J.

PREVALENCE AND RISK FACTORS FOR NON- ALCOHOLIC FATTY LIVER DISEASE AMONG AN URBAN AGING ADULT SRI LANKAN POPULATION– RAGAMA HEALTH STUDY 7-YEAR FOLLOW.

YOUR HEALTH SCREENING RESULTS

Diabetes Fact Sheet in Korea 2016.

From ESH 2016 | LB 3: Davide Agnoletti, MD

(Syndrome X, Insulin Resistance syndrome)

Effect of age, gender and cardiovascular risk factors on carotid distensibility during 6- year follow-up. The cardiovascular risk in Young Finns study

GLYPICAN-4 LEVELS IN RELATION WITH HORMONAL AND METABOLIC PROFILE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME Doç.Dr.Özlem ALTINKAYA.

Raw data Log-transformed data Male age log age Female age log age

Dietary patterns in a group of medical students

A longitudinal analysis on associations of adiponectin levels with metabolic syndrome and carotid artery intima-media thickness. The Cardiovascular Risk.

Baseline characteristics and effectiveness results

Insulin resistance in prepubertal children

HbA1c 1245_0025final study-report-body. Table : 1 HbA1c (%) change from baseline MMRM results over time − FAS (OC−AD)

ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH CRITERIA FOR THE CLINICAL DIAGNOSIS OF THE METABOLIC SYNDROME AS PROPOSED BY THE NCEP-ATP III Metabolic.

Supplementary material

Effect of age, gender and cardiovascular risk factors on carotid distensibility during 6- year follow-up. The cardiovascular risk in Young Finns study

Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.

Effect of Metabolic Surgery on diabetes and hypertension

Clinical Characteristics

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

برنامه غربالگری و بیماریابی بیماری های قلبی عروقی و عوامل خطر آن در استان فارس معاونت بهداشتی دانشگاه علوم پزشکی شیراز واحد غیر واگیر برنامه قلب و عروق.

Diabetes Fact Sheet in Korea 2016.

Combined Association of Cardiorespiratory Fitness and Body Fatness With Cardiometabolic Risk Factors in Older Norwegian Adults: The Generation 100 Study

Health-promoting lifestyles and cardio-metabolic risk factors among international students in South Korea Chun-Ja Kim, PhD, RN, JeeWon Park, PhD, RN,

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

A B D C Total adiponectin (μg/ml ) Hb ( g / dl ) r = p = 0.003

Level of risk factor control in the overall sample and by gender

Adjusted OR and SE for BMI≥30 kg/m2, BMI 25–29. 9 kg/m2, HbA1c≥6

Obesity Eppie Habashi.

Mean adjusted levels in each group for the following cardiometabolic risk factors at 3 and 12 months postpartum: (A) systolic blood pressure, (B) diastolic.

Adjusted OR and SE for BMI≥30 kg/m2, BMI 25–29. 9 kg/m2, HbA1c≥6

Fig. 3. Differences in the prevalence of albuminuria after comorbidity stratification. (A) Obesity defined by a body mass index ≥25 kg/m2, (B) central.

Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. Changes of major clinical and biochemical.

Presentation transcript:

Appendix Table 1 . Clinical Characteristics of the subjects enrolled in this study Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53 63.7 ± 0.80 24.3 ± 0.25 87.2 ± 0.76 146.8± 4.30 130.0±1.10 69.8±0.93 45.7±1.09 162.3±6.94 6.72 ±0.17 3.94 ±0.25 3.63 ±0.06 18.8% 37.5% 7.5% 1.3% 73.1% 55.0% 45.0% 86/52 63.5±0.87 22.7±0.27 80.8±0.70 128.6± 4.63 125.1±1.02 68.2±1.01 55.2±1.18 113.7±7.50 6.66 ±0.16 3.26 ±0.22 1.46 ±0.06 21.0% 25.4% 8.0% 0.7% 32.6% 3.0% 31.2% Men/Female Age (years) BMI (kg/m2) Waist circumference (cm) Fasting Plasma Glucose (mg/dl) Systolic Blood Pressure (mmHg) Diastolic Blood Pressure (mmHg) HDL-cholesterol (mg/dl) Triglycerides (mg/dl) HbA1c (%) HOMA-IR Number of Risk Factors Medication of Diabetes Diet alone Oral hypoglycemic agents Insulin Insulin + oral hypoglycemic agents Medication of Hypertension (%) Medication of Hyperlipidemia (%) Coronary artery disease (%)